Abstract
Methods
We retrospectively reviewed the medical records of 4905 consecutive patients who underwent glaucoma surgery (trabeculectomy or valve implant surgery) from January 1, 1988 to March 31, 2013.
Results
There were a total of 14 late-onset endophthalmitis (0.29%) cases associated with glaucoma surgery occurring at 1 year to 21 years postoperatively. Six cases (6/993, 0.60%) occurred after valve implantation and the other 8 cases (8/3912, 0.20%) occurred after trabeculectomy (p = 0.046). All but one patient were injected with fortified vancomycin and ceftazidim. Four patients also received a vitrectomy with the injection. The implanted valve was removed in 2 cases. In four cases, organisms were found in the culture (staphylococcus.aureus, streptococcus viridians, propionibacterium acnes and candida parapsilosis). After 1 year, only 4 patients achieved a visual acuity above 4/200 compared with other patients who had a final visual acuity of hand motion or worse. Three patients (33%) who developed endophthalmitis underwent other intraocular procedures.
Conclusions
Late-onset endophthalmitis associated with glaucoma surgery can often occur with fulminant sight-threatening complications. Due to devastating sequelae, the surgeon should carefully check the surgery site in the patients who underwent glaucoma surgery at every follow-up visit. Delayed endophthalmitis after glaucoma surgery still carries a poor visual prognosis and its onset is difficult to predict. Therefore, patients who undergo glaucoma surgery should be educated and carefully evaluated during regular follow-ups.
References
1. Aaberg TM Jr, Flynn HW Jr, Schiffman J, Newton J. Nosocomial acute-onset postoperative endophthalmitis survey. A 10-year review of incidence and outcomes. Ophthalmology. 1998; 105:1004–10.
2. Eifrig CW, Flynn HW Jr, Scott IU, Newton J. Acute-onset postoperative endophthalmitis: review of incidence and visual outcomes (1995-2001). Ophthalmic Surg Lasers. 2002; 33:373–8.
3. Kattan HM, Flynn HW Jr, Pflugfelder SC, et al. Nosocomial endophthalmitis survey. Current incidence of infection after intraocular surgery. Ophthalmology. 1991; 98:227–38.
4. Wu PC, Kuo HK, Li M, et al. Nosocomial postoperative endophthalmitis: a 14-year review. Graefes Arch Clin Exp Ophthalmol. 2006; 244:920–9.
5. Price FW Jr, Wellemeyer M. Long-term results of Molteno implants. Ophthalmic Surg. 1995; 26:130–5.
6. Nguyen QH, Budenz DL, Parrish RK 2nd. Complications of Baerveldt glaucoma drainage implants. Arch Ophthalmol. 1998; 116:571–5.
7. Djodeyre MR, Peralta Calvo J, Abelairas Gomez J. Clinical evaluation and risk factors of time to failure of Ahmed Glaucoma Valve implant in pediatric patients. Ophthalmology. 2001; 108:614–20.
8. Morad Y, Donaldson CE, Kim YM, et al. The Ahmed drainage implant in the treatment of pediatric glaucoma. Am J Ophthalmol. 2003; 135:821–9.
9. Johnson MW, Doft BH, Kelsey SF, et al. The Endophthalmitis Vitrectomy Study. Relationship between clinical presentation and microbiologic spectrum. Ophthalmology. 1997; 104:261–72.
10. Busbee BG, Recchia FM, Kaiser R, et al. Bleb-associated endophthalmitis: clinical characteristics and visual outcomes. Ophthalmology. 2004; 111:1495–503. discussion 1503.
11. Higginbotham EJ, Stevens RK, Musch DC, et al. Bleb-related endophthalmitis after trabeculectomy with mitomycin C. Ophthalmology. 1996; 103:650–6.
12. Greenfield DS, Suñer IJ, Miller MP, et al. Endophthalmitis after filtering surgery with mitomycin. Arch Ophthalmol. 1996; 114:943–9.
13. Uhm KB, Kim TW, Kim JH, Hong C. Risk Factors for the Development of Thin-walled Blebs after Mitomycin C Trabeculectomy. J Korean Ophthalmol Soc. 1996; 37:1032–44.
14. Parrish R, Minckler D. “Late endophthalmitis”. –filtering surgery time bomb? Ophthalmology. 1996; 103:1167–8.
15. Mandelbaum S, Forster RK. Endophthalmitis associated with filtering blebs. Int Ophthalmol Clin. 1987; 27:107–11.
16. Al-Torbak AA, Al-Shahwan S, Al-Jadaan I, et al. Endophthalmitis associated with the Ahmed glaucoma valve implant. Br J Ophthalmol. 2005; 89:454–8.
17. Francis BA, DiLoreto DA Jr, Chong LP, Rao N. Late-onset bacteria endophthalmitis following glaucoma drainage implantation. Ophthalmic Surg Lasers Imaging. 2003; 34:128–30.
18. Kil YG, Jin SM, Chung DY. A case of late onset bleb-related endophthalmitis after trabeculectomy with mitomycin C. J Korean Ophthalmol Soc. 1999; 40:2036–42.
19. Cha SC, Lee KW, Hahn DK. Late onset endophthalmitis following filtering surgery. J Korean Ophthalmol Soc. 1988; 29:195–9.
20. Kim JH, Sohn YH, Uhm KB, Hong C. Two cases of bleb-related endophthalmitis after trabeculectomy with mitomycin C. J Korean Ophthalmol Soc. 1997; 38:336–42.
21. Jampel HD, Quigley HA, Kerrigan-Baumrind LA, et al. Risk factors for late-onset infection following glaucoma filtration surgery. Arch Ophthalmol. 2001; 119:1001–8.
22. Mochizuki K, Jikihara S, Ando Y, et al. Incidence of delayed onset infection after trabeculectomy with adjunctive mitomycin C or 5-fluorouracil treatment. Br J Ophthalmol. 1997; 81:877–83.
23. Song A, Scott IU, Flynn HW Jr, Budenz DL. Delayed-onset bleb-associated endophthalmitis: clinical features and visual acuity outcomes. Ophthalmology. 2002; 109:985–91.
24. Fanous MM, Cohn RA. Propionibacterium endophthalmitis following Molteno tube repositioning. J Glaucoma. 1997; 6:201–2.
25. Chen PP, Palmberg PF. Needling revision of glaucoma drainage device filtering blebs. Ophthalmology. 1997; 104:1004–10.
26. Beck AD, Wilson WR, Lynch MG, et al. Trabeculectomy with adjunctive mitomycin C in pediatric glaucoma. Am J Ophthalmol. 1998; 126:648–57.
27. Sidoti PA, Belmonte SJ, Liebmann JM, Ritch R. Trabeculectomy with mitomycin-C in the treatment of pediatric glaucomas. Ophthalmology. 2000; 107:422–9.
28. Gedde SJ, Scott IU, Tabandeh H, et al. Late endophthalmitis associated with glaucoma drainage implants. Ophthalmology. 2001; 108:1323–7.
29. Perkins TW. Endophthalmitis after placement of a Molteno implant. Ophthalmic Surg. 1990; 21:733–4.
30. Ellis BD, Varley GA, Kalenak JW, et al. Bacterial endophthalmitis following cataract surgery in an eye with a preexisting Molteno implant. Ophthalmic Surg. 1993; 24:117–8.
31. Mather R, Karenchak LM, Romanowski EG, Kowalski RP. Fourth generation fluoroquinolones: new weapons in the arsenal of ophthalmic antibiotics. Am J Ophthalmol. 2002; 133:463–6.
32. Results of the Endophthalmitis Vitrectomy Study. A randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis. Endophthalmitis Vitrectomy Study Group. Arch Ophthalmol. 1995; 113:1479–96.
33. Tsai JC, Johnson CC, Kammer JA, Dietrich MS. The Ahmed shunt versus the Baerveldt shunt for refractory glaucoma II: longer-term outcomes from a single surgeon. Ophthalmology. 2006; 113:913–7.
Table 1.
Type of surgery | Total cases (n) | Infected cases (n) |
---|---|---|
Trabeculectomy | 3,912 | 8 (0.20%) |
Valve implant surgery | 993 | 6 (0.60%) |
Total | 4,905 | 14 (0.29%) |
p-value | − | 0.046∗ |
Table 2.
Table 3.
Case no. | Sex/Age (years) | Associated systemic disease | Glaucoma diagnosis | ∗Symptom duration | Presenting visual acuity | †Interval | Type of surgery | Mitomycin-C use | Status of glaucoma surgery site | Treatment | Culture organism | Other operation (time) | ‡Final visual acuity |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | M/68 | HBP | 2nd glaucoma | 1 day | 8/200 | 16 years | Trabeculectomy | Yes | Nearly melted conjunctiva, leak (+) | Intravitreal vancomycin + ceftazidim injection | No growth | − | 20/200 |
2 | M/49 | none | CACG | 2 days | LP(+) | 21 years | Trabeculectomy | Yes | Pus tinged bleb | Intravitreal, intracameral and subconjunctival vancomycin + ceftazidim injection | No growth | − | HM |
3 | M/33 | none | POAG | the day | CF | 9 years | Trabeculectomy | Yes | Bleb thinning, leak (+) | Intravitreal and subconjunctival vancomycin + ceftazidim injection | No growth | − | 4/200 |
4 | M/49 | none | POAG | 1 day | HM | 2 years and 6 months | Trabeculectomy | Yes | Pus tinged bleb | Intravitreal vancomycin + ceftazidim injection, ppV | Staphyococcus. aureus | − | LP(-) |
5 | M/50 | none | POAG | 1 day | HM | 19 years | Trabeculectomy | No | Pus tinged bleb | Intravitreal vancomycin + ceftazidim injection, ppV | No growth | Phacoemulsification + PCL in sertion (14 years after trabeculectomy) | LP(-) |
6 | M/56 | none | 2nd glaucoma | 2 days | 12/200 | 13 months | Ahmed valve implantation + scleral graft | No | Thin conjunctiva on valve | Intravitreal vancomycin + ceftazidim injection | No growth | PKP (twice, 3 months prior to ahmed valve implantation) | LP(-) |
7 | M/59 | none | 2nd glaucoma | the day | LP(+) | 8 years and 6 months | Ahmed valve implantation | No | Conjunctival inflammation with exposed valve | Intravitreal vancomycin + ceftazidim injection | No growth | l’ closure, ppV (1 year prior to ahmed valve implantation), PKP (3 years after ahmed valve implanatation) | LP(+) |
8 | M/80 | DM | POAG | 1 year | LP(-) | 1 year | Ahmed valve implantation | NR | Bullae on conjunctiva | Ahmed valve removal, evisceration | No growth | − | LP(-) |
9 | M/68 | none | Advanced glaucoma (NVG + AACG) | 1 day | HM | 5 years | Molteno tube implantation | No | Well positioned valve | Intravitreal vancomycin + ceftazidim injection | No growth | ppV (6 months after Molteno tube implantation) | HM |
10 | M/56 | none | Uveitic glaucoma | 2 days | HM | 8 months | Trabeculectomy | Yes | Pus tinged bleb | Intravitreal vancomycin + ceftazidim injection, ppV | Streptococcus viridans | Phacoemulsification + PCL in sertion (8 years prior to trabeculectomy) | LP(-) |
11 | M/34 | none | Secondary glaucoma | 2 days | HM | 1 year | Ahmed valve implantation + ppv | NR | Well positioned valve | Intravitreal vancomycin + ceftazidim injection, ppV | Propionibacterium acnes | Ciliary body retension cyst removal (1 year 4 months prior to valve surgery) | LP(-) |
12 | M/64 | none | POAG | 10 days | 0.16 | 12 years | Ahmed valve implantation | NR | Ahmed valve tip exposure | Intravitreal vancomycin + ceftazidim injection, ahmed valve removal | No growth | Trabeculectomy (7 years prior to ahmed valve implantation) phacoemulsification + PCL in sertion (8 years prior to ahmed valve implantation | 50/200 |
13 | F/69 | DM | POAG | 30 days | LP(-) | 7 years | Trabeculectomy + pressure regulator insertion | No | Exposed tube with whitish pus | Tube removal & AC irrigation & intracameral vancomycin + ceftazidim injection | Candida parapsilosis | Trabeculectomy (6 years prior to 2nd trabeculectomy) | LP(-) |
14 | F/36 | none | POAG | 2 days | CF | 13 years | Trabeculectomy | Yes | Bleb thinning, leak(+) | Topical fortified antibiotics | No growth | Trabeculectomy (2 years prior to 2nd trabeculectomy) | 40/200 |
HBP = high blood pressure; CACG = chronic angle closure glaucoma; POAG = primary open angle glaucoma; PCL = posterior chamber lens; AACG = acute angle closure glaucoma; NVG = neovascular glaucoma; DM = diabetes mellitus; LP (+) = light perception; CF = counting fingers; HM = handmotion; LP (-) = no light perception; ppV = pars plana vitrectomy; NR = notrecorded; PKP = penetrating keratoplasty.